Bayer AG (BAYN):企業の財務・戦略的SWOT分析

◆英語タイトル:Bayer AG (BAYN) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15512
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:77
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Bayer AG (BAYN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Bayer AG (Bayer) carries out the research, development, production and commercialization of products for human and animal health care, and agriculture. It provides medicines for cardiovascular diseases, women’s health, cancer, hematology, ophthalmology and other indications. The company’s product portfolio includes prescription products, specialty therapeutics, animal health care products, diagnostic imaging equipment, nonprescription (over-the-counter – OTC) products, seeds, crop protection solutions and nonagricultural pest control solutions. Bayer markets its healthcare and crop protection products essentially through wholesalers, pharmacies, hospitals and retailers. It operates through a network of subsidiaries in Asia-Pacific, Europe, North America, Latin America, Africa and the Middle East. Bayer is headquartered in Leverkusen, Germany.

Bayer AG Key Recent Developments

Mar 17,2019 Bayer statement on new 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease
Mar 08,2019 Bayer files for darolutamide marketing approval in Japan
Mar 08,2019 Orion and Bayer Submit Marketing Authorization Application to EMA for Darolutamide
Mar 05,2019 Bayer files prostate cancer drug darolutamide in Japan

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Bayer AG – Key Facts
Bayer AG – Key Employees
Bayer AG – Key Employee Biographies
Bayer AG – Major Products and Services
Bayer AG – History
Bayer AG – Company Statement
Bayer AG – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Bayer AG – Business Description
Business Segment: All Other Segments
Overview
Performance
Business Segment: Animal Health
Overview
Performance
Key Stats
Business Segment: Consumer Health
Overview
Performance
Key Stats
Business Segment: Crop Science
Overview
Performance
Key Stats
Business Segment: Pharmaceuticals
Overview
Performance
Key Stats
Geographical Segment: Asia Pacific
Performance
Geographical Segment: Europe, Middle East and Africa
Performance
Geographical Segment: Latin America
Performance
Geographical Segment: North America
Performance
R&D Overview
Bayer AG – Corporate Strategy
Bayer AG – SWOT Analysis
SWOT Analysis – Overview
Bayer AG – Strengths
Bayer AG – Weaknesses
Bayer AG – Opportunities
Bayer AG – Threats
Bayer AG – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Bayer AG, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Bayer AG, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Bayer AG, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 17, 2019: Bayer statement on new 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease
Mar 08, 2019: Bayer files for darolutamide marketing approval in Japan
Mar 08, 2019: Orion and Bayer Submit Marketing Authorization Application to EMA for Darolutamide
Mar 05, 2019: Bayer files prostate cancer drug darolutamide in Japan
Feb 27, 2019: Bayer completes rolling submission for darolutamide in U.S.
Feb 27, 2019: Bayer increases sales and earnings – leader in agriculture after acquisition
Feb 15, 2019: Bayer gains full rights to TRK inhibitors Vitrakvi, LOXO-195 as Eli Lilly completes Loxo Oncology deal
Feb 15, 2019: Bayer Bags Full Vitrakvi Rights As Lilly Signs Off Loxo Buy
Feb 15, 2019: Bayer antes up on Vitrakvi just as Roche rival wins fast review
Feb 13, 2019: Bayer donates $130,000 to 13 domestic violence shelters through new Grants Fur Families program
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Bayer AG, Key Facts
Bayer AG, Key Employees
Bayer AG, Key Employee Biographies
Bayer AG, Major Products and Services
Bayer AG, History
Bayer AG, Subsidiaries
Bayer AG, Joint Venture
Bayer AG, Key Competitors
Bayer AG, Ratios based on current share price
Bayer AG, Annual Ratios
Bayer AG, Annual Ratios (Cont...1)
Bayer AG, Annual Ratios (Cont...2)
Bayer AG, Interim Ratios
Bayer AG, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Bayer AG, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Bayer AG, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Bayer AG, Performance Chart (2014 - 2018)
Bayer AG, Ratio Charts
Bayer AG, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Bayer AG, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Bayer AG (BAYN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Diebold Nixdorf AG.:企業の戦略・SWOT・財務分析
    Diebold Nixdorf AG. - Strategy, SWOT and Corporate Finance Report Summary Diebold Nixdorf AG. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • BENEO GmbH:戦略・SWOT・企業財務分析
    BENEO GmbH - Strategy, SWOT and Corporate Finance Report Summary BENEO GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Cantargia AB (CANTA):企業の財務・戦略的SWOT分析
    Summary Cantargia AB (Cantargia), a subsidiary of Lund University Bioscience AB is a biotechnology company that develops antibody based cancer treatments. The company’s product candidate CAN04 is used for the treatment of several cancers including non-small cell lung cancer and pancreatic cancer. It …
  • DiscGenics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary DiscGenics Inc (DiscGenics) is a biotechnology company that develops advanced spinal therapeutics. The company develops therapies to treat patients with intervertebral disc diseases. It provides products such as Injectable Discogenic Cell Therapy (IDCT), developed for treating patients with …
  • Alliance Resource Partners LP:企業の戦略・SWOT・財務情報
    Alliance Resource Partners LP - Strategy, SWOT and Corporate Finance Report Summary Alliance Resource Partners LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Abercrombie & Fitch Co.:企業の戦略・SWOT・財務情報
    Abercrombie & Fitch Co. - Strategy, SWOT and Corporate Finance Report Summary Abercrombie & Fitch Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • William Demant Holding AS (WDH):医療機器:M&Aディール及び事業提携情報
    Summary William Demant Holding AS (WDH) is a provider of hearing healthcare solutions that develops, manufactures and distributes products designed to aid people with hearing loss. The company offers hearing devices and implants, diagnostic instruments and personal communication devices. Its product …
  • Compagnie Financiere Richemont SA:戦略・SWOT・企業財務分析
    Compagnie Financiere Richemont SA - Strategy, SWOT and Corporate Finance Report Summary Compagnie Financiere Richemont SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Star Phoenix Group Ltd (STA):企業の財務・戦略的SWOT分析
    Star Phoenix Group Ltd (STA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Aalberts Industries NV:企業の戦略・SWOT・財務分析
    Aalberts Industries NV - Strategy, SWOT and Corporate Finance Report Summary Aalberts Industries NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Bank of Singapore Ltd.:企業の戦略・SWOT・財務情報
    Bank of Singapore Ltd. - Strategy, SWOT and Corporate Finance Report Summary Bank of Singapore Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Orsted AS (ORSTED):企業の財務・戦略的SWOT分析
    Orsted AS (ORSTED) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Nippon Sheet Glass Co Ltd:戦略・SWOT・企業財務分析
    Nippon Sheet Glass Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Nippon Sheet Glass Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Terramin Australia Ltd:企業の戦略・SWOT・財務分析
    Terramin Australia Ltd - Strategy, SWOT and Corporate Finance Report Summary Terramin Australia Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • QuadraMed Corp:医療機器:M&Aディール及び事業提携情報
    Summary Quadramed Corporation (Quadramed), is a N. Harris Computer Corp., is a healthcare technologies and service provider. It provides solutions to various healthcare organizations to improve the safety, efficiency and quality of patient care. The company's solutions enable its clients in streamli …
  • Tethys Oil AB (TETY):企業の財務・戦略的SWOT分析
    Summary Tethys Oil AB (Tethys Oil) is an upstream oil and gas company that offers exploration, development and production of oil and natural gas reserves. The company holds onshore exploration licences in Lithuania and France. Tethys Oil holds Gargzdai license, Rietavas license and Raseiniai license …
  • Esso (Thailand) Public Company Ltd (ESSO):企業の財務・戦略的SWOT分析
    Esso (Thailand) Public Company Ltd (ESSO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • IRX Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary IRX Therapeutics Inc (IRX Therapeutics) is a clinical-stage bioresearch company that develops immunotherapies which reduces the immune suppression. The company provides product that overcomes cancer induced immune suppression and restores anti-tumor response. It offers product IRX-2 which is …
  • Vergnet SA (ALVER):企業の財務・戦略的SWOT分析
    Vergnet SA (ALVER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Litha Healthcare Group Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Litha Healthcare Group Ltd (Litha Healthcare), formerly Myriad Medical Holdings Limited, a subsidiary of Endo International plc is a healthcare company that provides its services to public and private hospitals, pharmacies, general, allied practitioners, and government healthcare programmes. …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆